| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 31.56% | Citigroup | → $100 | Upgrades | Neutral → Buy |
| 11/03/2023 | 5.25% | Piper Sandler | $100 → $80 | Maintains | Overweight |
| 11/03/2023 | 18.41% | Susquehanna | $95 → $90 | Maintains | Positive |
| 11/03/2023 | 18.41% | Morgan Stanley | $96 → $90 | Maintains | Overweight |
| 11/03/2023 | 18.41% | Keybanc | $95 → $90 | Maintains | Overweight |
| 11/03/2023 | 11.83% | Needham | $100 → $85 | Maintains | Buy |
| 10/24/2023 | 24.98% | Susquehanna | $100 → $95 | Maintains | Positive |
| 10/11/2023 | 26.3% | Morgan Stanley | $101 → $96 | Maintains | Overweight |
| 08/07/2023 | 31.56% | Needham | → $100 | Reiterates | Buy → Buy |
| 08/04/2023 | 32.88% | Morgan Stanley | $97 → $101 | Maintains | Overweight |
| 08/04/2023 | 31.56% | Susquehanna | $105 → $100 | Maintains | Positive |
| 08/04/2023 | 18.41% | Wells Fargo | $80 → $90 | Maintains | Equal-Weight |
| 08/04/2023 | 13.14% | Mizuho | $89 → $86 | Maintains | Neutral |
| 08/04/2023 | 44.72% | Rosenblatt | $125 → $110 | Maintains | Buy |
| 08/03/2023 | 64.45% | Rosenblatt | → $125 | Reiterates | Buy → Buy |
| 07/25/2023 | 38.14% | Susquehanna | $90 → $105 | Maintains | Positive |
| 07/20/2023 | 38.14% | Stifel | $95 → $105 | Maintains | Equal-Weight |
| 07/20/2023 | 17.09% | Mizuho | $79 → $89 | Maintains | Neutral |
| 07/20/2023 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 07/18/2023 | 21.04% | Citigroup | $76 → $92 | Maintains | Neutral |
| 07/14/2023 | 36.82% | Truist Securities | $95 → $104 | Maintains | Buy |
| 06/13/2023 | 18.41% | Susquehanna | → $90 | Reiterates | Positive → Positive |
| 05/05/2023 | 24.98% | Truist Securities | $94 → $95 | Maintains | Buy |
| 05/05/2023 | 5.25% | Wells Fargo | $85 → $80 | Maintains | Equal-Weight |
| 05/05/2023 | 24.98% | Stifel | $100 → $95 | Maintains | Equal-Weight |
| 05/05/2023 | -0.01% | Citigroup | $85 → $76 | Maintains | Neutral |
| 05/05/2023 | 24.98% | Keybanc | $100 → $95 | Maintains | Overweight |
| 04/25/2023 | 24.98% | Susquehanna | $100 → $95 | Maintains | Positive |
| 03/08/2023 | 44.72% | Needham | → $110 | Reiterates | → Buy |
| 03/02/2023 | 44.72% | Needham | → $110 | Reiterates | → Buy |
| 02/06/2023 | 14.46% | Goldman Sachs | $76 → $87 | Maintains | Neutral |
| 02/03/2023 | 11.83% | Wells Fargo | $80 → $85 | Maintains | Equal-Weight |
| 02/03/2023 | 31.56% | Susquehanna | $85 → $100 | Maintains | Positive |
| 02/03/2023 | 39.46% | B. Riley Securities | $86 → $106 | Maintains | Buy |
| 02/03/2023 | 23.67% | Truist Securities | $85 → $94 | Maintains | Buy |
| 02/03/2023 | 28.93% | Credit Suisse | $85 → $98 | Maintains | Neutral |
| 02/03/2023 | 30.25% | Morgan Stanley | $80 → $99 | Maintains | Overweight |
| 02/03/2023 | 11.83% | Citigroup | $74 → $85 | Maintains | Neutral |
| 02/03/2023 | 38.14% | Raymond James | $90 → $105 | Maintains | Strong Buy |
| 02/03/2023 | 3.93% | Mizuho | $72 → $79 | Maintains | Neutral |
| 02/03/2023 | 31.56% | Piper Sandler | $80 → $100 | Maintains | Overweight |
| 02/03/2023 | 44.72% | Needham | $82 → $110 | Maintains | Buy |
| 02/03/2023 | 31.56% | Keybanc | $85 → $100 | Maintains | Overweight |
| 01/27/2023 | 5.25% | Wells Fargo | $65 → $80 | Maintains | Equal-Weight |
| 01/18/2023 | -2.64% | Citigroup | $62 → $74 | Maintains | Neutral |
| 11/29/2022 | 5.25% | Stifel | $77 → $80 | Maintains | Buy |
| 11/16/2022 | 11.83% | Credit Suisse | → $85 | Initiates Coverage On | → Neutral |
| 11/07/2022 | -0.01% | Goldman Sachs | $67 → $76 | Maintains | Neutral |
| 11/04/2022 | -5.28% | Mizuho | $75 → $72 | Maintains | Neutral |
| 11/04/2022 | 5.25% | Morgan Stanley | $82 → $80 | Maintains | Overweight |
| 11/04/2022 | 18.41% | Raymond James | $110 → $90 | Maintains | Strong Buy |
| 11/04/2022 | 5.25% | Piper Sandler | $100 → $80 | Maintains | Overweight |
| 10/11/2022 | -14.48% | Wells Fargo | $75 → $65 | Maintains | Equal-Weight |
| 10/11/2022 | -18.43% | Citigroup | $72 → $62 | Maintains | Neutral |
| 08/03/2022 | -1.33% | Mizuho | $72 → $75 | Maintains | Neutral |
| 08/03/2022 | 13.14% | B. Riley Securities | $78 → $86 | Maintains | Buy |
| 08/03/2022 | 7.88% | Morgan Stanley | $81 → $82 | Maintains | Overweight |
| 08/03/2022 | -5.28% | Cowen & Co. | $60 → $72 | Maintains | Outperform |
| 08/03/2022 | -1.33% | Wells Fargo | $60 → $75 | Maintains | Equal-Weight |
| 08/03/2022 | 21.04% | Needham | $75 → $92 | Maintains | Buy |
| 07/11/2022 | -21.06% | Wells Fargo | $70 → $60 | Maintains | Equal-Weight |
| 06/29/2022 | -2.64% | B of A Securities | $85 → $74 | Maintains | Buy |
| 06/28/2022 | -1.33% | Stifel | $70 → $75 | Upgrades | Hold → Buy |
| 06/15/2022 | 2.62% | B. Riley Securities | $85 → $78 | Maintains | Buy |
| 06/10/2022 | 6.56% | Morgan Stanley | $85 → $81 | Maintains | Overweight |
| 05/10/2022 | 11.83% | BMO Capital | $95 → $85 | Maintains | Outperform |
| 05/10/2022 | 18.41% | Needham | $105 → $90 | Maintains | Buy |
| 05/10/2022 | 11.83% | B. Riley Securities | $105 → $85 | Maintains | Buy |
| 05/10/2022 | 11.83% | Keybanc | $100 → $85 | Maintains | Overweight |
| 05/10/2022 | -7.91% | Wells Fargo | $80 → $70 | Maintains | Equal-Weight |
| 05/10/2022 | -5.28% | Mizuho | $75 → $72 | Maintains | Neutral |
| 05/10/2022 | -5.28% | Citigroup | $78 → $72 | Maintains | Neutral |
| 05/09/2022 | 11.83% | Morgan Stanley | $100 → $85 | Maintains | Overweight |
| 04/08/2022 | 3.93% | Truist Securities | $94 → $79 | Maintains | Buy |
| 03/28/2022 | 3.93% | Goldman Sachs | → $79 | Downgrades | Buy → Neutral |
| 03/09/2022 | 38.14% | UBS | $98 → $105 | Maintains | Buy |
| 02/04/2022 | 64.45% | Rosenblatt | $120 → $125 | Maintains | Buy |
| 01/31/2022 | 21.04% | UBS | $82 → $92 | Upgrades | Neutral → Buy |
| 12/01/2021 | 43.4% | Jefferies | $98 → $109 | Maintains | Buy |
| 11/05/2021 | 44.72% | Raymond James | $90 → $110 | Maintains | Strong Buy |
| 11/05/2021 | 31.56% | Morgan Stanley | $95 → $100 | Maintains | Overweight |
| 11/05/2021 | 11.83% | Mizuho | $81.5 → $85 | Maintains | Neutral |
| 11/05/2021 | 57.87% | Credit Suisse | $100 → $120 | Maintains | Outperform |
| 11/05/2021 | 31.56% | Keybanc | $95 → $100 | Maintains | Overweight |
| 10/14/2021 | -0.01% | Stifel | → $76 | Initiates Coverage On | → Hold |
| 10/13/2021 | 24.98% | Morgan Stanley | $190 → $95 | Maintains | Overweight |
| 10/13/2021 | 102.6% | UBS | → $154 | Initiates Coverage On | → Neutral |
| 10/12/2021 | 103.92% | Wells Fargo | $165 → $155 | Maintains | Equal-Weight |
| 09/28/2021 | 117.08% | Wells Fargo | → $165 | Downgrades | Overweight → Equal-Weight |
| 09/17/2021 | 143.39% | B of A Securities | $170 → $185 | Maintains | Buy |
| 08/04/2021 | 149.97% | Morgan Stanley | $177 → $190 | Maintains | Overweight |
| 08/04/2021 | 156.55% | Susquehanna | $190 → $195 | Maintains | Positive |
| 08/04/2021 | 156.55% | Rosenblatt | $180 → $195 | Maintains | Buy |
| 08/04/2021 | 176.28% | Needham | $200 → $210 | Maintains | Buy |
| 08/04/2021 | 149.97% | Keybanc | $185 → $190 | Maintains | Overweight |
| 07/15/2021 | 110.5% | Mizuho | $165 → $160 | Downgrades | Buy → Neutral |
| 07/06/2021 | 143.39% | Keybanc | $180 → $185 | Maintains | Overweight |
| 05/07/2021 | 136.81% | Rosenblatt | $165 → $180 | Maintains | Buy |
| 05/07/2021 | 132.86% | Morgan Stanley | $165 → $177 | Maintains | Overweight |
| 03/23/2021 | 147.34% | Longbow Research | → $188 | Upgrades | Neutral → Buy |
| 02/05/2021 | 117.08% | Rosenblatt | $150 → $165 | Maintains | Buy |
| 02/05/2021 | 107.87% | Mizuho | $152 → $158 | Maintains | Buy |
| 02/05/2021 | 155.23% | Jefferies | $179 → $194 | Maintains | Buy |
| 02/05/2021 | 144.7% | B. Riley Securities | $180 → $186 | Maintains | Buy |
| 02/05/2021 | 136.81% | JP Morgan | $135 → $180 | Maintains | Overweight |
| 02/05/2021 | 136.81% | Credit Suisse | $145 → $180 | Maintains | Outperform |
| 02/05/2021 | 117.08% | Morgan Stanley | $159 → $165 | Maintains | Overweight |
| 02/05/2021 | 130.23% | Keybanc | $170 → $175 | Maintains | Overweight |
| 02/03/2021 | — | Vertical Research | Downgrades | Buy → Neutral | |
| 01/19/2021 | 136.81% | Raymond James | $140 → $180 | Maintains | Strong Buy |
| 01/13/2021 | 163.12% | Needham | $130 → $200 | Maintains | Buy |
| 01/06/2021 | 123.65% | KeyBanc | $165 → $170 | Maintains | Overweight |
| 12/14/2020 | 109.18% | Morgan Stanley | $140 → $159 | Maintains | Overweight |
| 11/06/2020 | 84.19% | Morgan Stanley | $131 → $140 | Maintains | Overweight |
| 11/06/2020 | 84.19% | Raymond James | $125 → $140 | Maintains | Strong Buy |
| 11/06/2020 | 97.34% | Rosenblatt | $130 → $150 | Reiterates | → Buy |
| 11/06/2020 | — | Citigroup | Downgrades | Buy → Neutral | |
| 11/06/2020 | 71.03% | BMO Capital | $118 → $130 | Maintains | Outperform |
| 11/06/2020 | 84.19% | Keybanc | $115 → $140 | Maintains | Overweight |
| 10/19/2020 | 72.35% | Morgan Stanley | → $131 | Upgrades | Equal-Weight → Overweight |
| 08/05/2020 | 71.03% | Needham | $140 → $130 | Maintains | Buy |
| 07/27/2020 | 84.19% | Needham | $130 → $140 | Maintains | Buy |
| 07/13/2020 | 64.45% | Raymond James | $115 → $125 | Maintains | Strong Buy |
| 07/07/2020 | 51.3% | Keybanc | $105 → $115 | Maintains | Overweight |
| 06/16/2020 | 43.4% | Morgan Stanley | $81 → $109 | Maintains | Equal-Weight |
| 06/03/2020 | 71.03% | Piper Sandler | $120 → $130 | Maintains | Overweight |
| 06/03/2020 | 57.87% | Citigroup | $104 → $120 | Maintains | Buy |
| 06/03/2020 | 53.93% | SunTrust Robinson Humphrey | $94 → $117 | Maintains | Buy |
| 06/03/2020 | 51.3% | Raymond James | $100 → $115 | Maintains | Strong Buy |
| 06/03/2020 | 71.03% | Needham | $100 → $130 | Maintains | Buy |
| 06/03/2020 | 38.14% | Keybanc | $100 → $105 | Maintains | Overweight |
| 05/08/2020 | 24.98% | CFRA | $110 → $95 | Maintains | Hold |
| 05/08/2020 | 11.83% | B. Riley Securities | $81 → $85 | Maintains | Neutral |
| 05/08/2020 | 31.56% | Needham | $96 → $100 | Maintains | Buy |
| 04/13/2020 | 23.67% | SunTrust Robinson Humphrey | $90 → $94 | Maintains | Buy |
| 04/09/2020 | 6.56% | B. Riley Securities | $70 → $81 | Maintains | Neutral |
| 04/09/2020 | 44.72% | Wells Fargo | $120 → $110 | Maintains | Overweight |
| 04/09/2020 | 51.3% | Susquehanna | $130 → $115 | Maintains | Positive |
| 04/09/2020 | 31.56% | JP Morgan | $115 → $100 | Maintains | Overweight |
| 04/08/2020 | 26.3% | Needham | $100 → $96 | Maintains | Buy |
| 04/03/2020 | 31.56% | Needham | $140 → $100 | Maintains | Buy |
| 03/31/2020 | 11.83% | Keybanc | $120 → $85 | Maintains | Overweight |
| 03/30/2020 | 49.98% | Citigroup | $121 → $114 | Maintains | Buy |
| 03/19/2020 | -7.91% | B. Riley Securities | $128 → $70 | Downgrades | Buy → Neutral |
| 03/18/2020 | 6.56% | Morgan Stanley | $107 → $81 | Maintains | Equal-Weight |
| 03/03/2020 | 51.3% | JP Morgan | $120 → $115 | Maintains | Overweight |
| 03/03/2020 | 68.4% | B. Riley Securities | $135 → $128 | Maintains | Buy |
| 03/03/2020 | 40.77% | Morgan Stanley | $109 → $107 | Maintains | Equal-Weight |
| 03/03/2020 | 57.87% | Rosenblatt | $132 → $120 | Maintains | Buy |
| 02/05/2020 | 44.72% | CFRA | $100 → $110 | Maintains | Hold |
| 02/05/2020 | 64.45% | Raymond James | $115 → $125 | Reiterates | → Strong Buy |
| 02/05/2020 | 71.03% | Credit Suisse | $110 → $130 | Maintains | Outperform |
| 02/05/2020 | 73.66% | Rosenblatt | $115 → $132 | Reiterates | → Buy |
| 01/21/2020 | 43.4% | Morgan Stanley | $102 → $109 | Maintains | Equal-Weight |
| 01/10/2020 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 01/07/2020 | 56.56% | SunTrust Robinson Humphrey | $113 → $119 | Maintains | Buy |
| 01/07/2020 | 57.87% | Keybanc | $110 → $120 | Maintains | Overweight |
| 12/20/2019 | 51.3% | Wells Fargo | $110 → $115 | Maintains | Overweight |
| 12/18/2019 | 34.19% | Morgan Stanley | $90 → $102 | Maintains | Equal-Weight |
| 12/04/2019 | 39.46% | SunTrust Robinson Humphrey | $104 → $106 | Maintains | Buy |
| 11/06/2019 | 51.3% | B. Riley Securities | $120 → $115 | Maintains | Buy |
| 11/06/2019 | 18.41% | Morgan Stanley | $84 → $90 | Maintains | Equal-Weight |
| 11/06/2019 | 43.4% | Citigroup | $104 → $109 | Maintains | Buy |
| 11/06/2019 | 44.72% | Wells Fargo | $115 → $110 | Maintains | Outperform |
| 10/30/2019 | 51.3% | Raymond James | → $115 | Upgrades | Market Perform → Strong Buy |
| 10/01/2019 | 44.72% | Keybanc | → $110 | Upgrades | Sector Weight → Overweight |
| 07/29/2019 | 51.3% | Wells Fargo | $105 → $115 | Maintains | Outperform |
| 07/09/2019 | — | Longbow Research | Initiates Coverage On | → Neutral | |
| 06/25/2019 | 38.14% | Wells Fargo | → $105 | Initiates Coverage On | → Outperform |
| 05/09/2019 | 57.87% | B. Riley Securities | $125 → $120 | Maintains | Buy |
| 05/09/2019 | 44.72% | BMO Capital | $118 → $110 | Maintains | Outperform |
| 05/09/2019 | 31.56% | Mizuho | $95 → $100 | Maintains | Buy |
| 05/06/2019 | 64.45% | B. Riley Securities | $105 → $125 | Maintains | Buy |
| 02/22/2019 | 18.41% | Cowen & Co. | → $90 | Initiates Coverage On | → Market Perform |
| 01/24/2019 | 18.41% | Needham | $100 → $90 | Downgrades | Strong Buy → Buy |
| 12/19/2018 | -1.33% | Morgan Stanley | $72 → $75 | Maintains | Equal-Weight |
| 11/13/2018 | 21.04% | BMO Capital | → $92 | Initiates Coverage On | → Outperform |
| 11/08/2018 | 34.19% | Jefferies | $115 → $102 | Maintains | Buy |
| 11/08/2018 | 31.56% | B. Riley Securities | $105 → $100 | Maintains | Buy |
What is the target price for Microchip Technology (MCHP)?
The latest price target for Microchip Technology (NASDAQ: MCHP) was reported by Citigroup on November 8, 2023. The analyst firm set a price target for $100.00 expecting MCHP to rise to within 12 months (a possible 31.56% upside). 47 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Microchip Technology (MCHP)?
The latest analyst rating for Microchip Technology (NASDAQ: MCHP) was provided by Citigroup, and Microchip Technology upgraded their buy rating.
When is the next analyst rating going to be posted or updated for Microchip Technology (MCHP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microchip Technology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microchip Technology was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Microchip Technology (MCHP) correct?
While ratings are subjective and will change, the latest Microchip Technology (MCHP) rating was a upgraded with a price target of $0.00 to $100.00. The current price Microchip Technology (MCHP) is trading at is $76.01, which is within the analyst's predicted range.